Clinical Study
Value of C-Reactive Protein as a Risk Factor for Acute Coronary Syndrome: A Comparison with Apolipoprotein Concentrations and Lipid Profile
Table 2
Characteristics of patients according to the type of ACS.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Presence of a statistically significant difference in the post hoc analysis. apoA-I: apolipoprotein A-I; apoB: apolipoprotein B; apoB : apoA-I: apolipoprotein B to apolipoprotein A-I ratio; BMI: body mass index; HDL-C: high-density lipoprotein cholesterol; hsCRP: high-sensitivity C-reactive protein; LDL-C: low-density lipoprotein cholesterol; LDL-C : HDL-C: low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio; non-HDL-C: nonhigh-density lipoprotein cholesterol; ns: not significant; NSTEMI: non-ST elevation myocardial infarction; STEMI: ST elevation myocardial infarction; TC: total cholesterol; TC : HDL-C: total cholesterol to high-density lipoprotein cholesterol ratio; TG: triglycerides; TG : HDL-C: triglycerides to high-density lipoprotein cholesterol ratio; UA: unstable angina. |